Chiral separation and determination of R/S-methamphetamine and its metabolite R/S-amphetamine in urine using LC-MS/MS.
暂无分享,去创建一个
[1] R. de la Torre,et al. MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant? , 2012, Front. Gene..
[2] B. Kasprzyk-Hordern,et al. Estimation of community-wide drugs use via stereoselective profiling of sewage. , 2012, The Science of the total environment.
[3] Reese T. Jones,et al. Stereoselectivity in the human metabolism of methamphetamine. , 2010, British journal of clinical pharmacology.
[4] P. Pávek,et al. New high-performance liquid chromatography method for the determination of (R)-warfarin and (S)-warfarin using chiral separation on a glycopeptide-based stationary phase. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[5] Jianxin Zhang,et al. [Monitoring precursor chemicals through enantiomer profiling of methamphetamine]. , 2009, Wei sheng yan jiu = Journal of hygiene research.
[6] D. Bush. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations. , 2008, Forensic science international.
[7] Jeong-Hill Park,et al. Monitoring precursor chemicals of methamphetamine through enantiomer profiling. , 2007, Forensic science international.
[8] K. Hara,et al. Simultaneous determination of methamphetamine and amphetamine in human urine using pipette tip solid-phase extraction and gas chromatography-mass spectrometry. , 2007, Journal of pharmaceutical and biomedical analysis.
[9] M. Hitosugi,et al. Stereoisomeric identification of norephedrine derived from methamphetamine or amphetamine: urinalysis results of 33 methamphetamine abusers and 1 amphetamine abuser in Japan. , 2007, Analytical Chemistry.
[10] M. Huestis,et al. Methamphetamine Disposition in Oral Fluid, Plasma, and Urine , 2007, Annals of the New York Academy of Sciences.
[11] S. Johansen,et al. Chiral separation and quantification of R/S-amphetamine, R/S-methamphetamine, R/S-MDA, R/S-MDMA, and R/S-MDEA in whole blood by GC-EI-MS. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[12] Heesun Chung,et al. Sensitive, rapid and validated gas chromatography/negative ion chemical ionization-mass spectrometry assay including derivatisation with a novel chiral agent for the enantioselective quantification of amphetamine-type stimulants in hair. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[13] K. Kuwayama,et al. Forensic application of chiral separation of amphetamine-type stimulants to impurity analysis of seized methamphetamine by capillary electrophoresis. , 2006, Forensic science international.
[14] A. Lua,et al. Enantiomeric quantification of (S)-(+)-methamphetamine in urine by an immunoaffinity column and liquid chromatography-electrospray-mass spectrometry. , 2006, Analytica chimica acta.
[15] Y. Giang,et al. Distribution characteristics of methamphetamine and amphetamine in urine and hair specimens collected from alleged methamphetamine users in northern Taiwan. , 2006, Analytica chimica acta.
[16] C. Cháfer-Pericás,et al. Application of solid-phase microextraction combined with derivatization to the enantiomeric determination of amphetamines. , 2006, Journal of pharmaceutical and biomedical analysis.
[17] Heesun Chung,et al. Simultaneous enantioselective determination of amphetamine and congeners in hair specimens by negative chemical ionization gas chromatography-mass spectrometry. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[18] Frank T Peters,et al. Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for enantioselective measurement of the designer drugs MDEA, MDMA, and MDA and its application to samples from a controlled study with MDMA. , 2005, Clinical chemistry.
[19] Y. Giang,et al. Simultaneous determination of amphetamine and methamphetamine enantiomers in urine by simultaneous liquid-liquid extraction and diastereomeric derivatization followed by gas chromatographic-isotope dilution mass spectrometry. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[20] Manami Nishida,et al. Miniaturized sample preparation method for determination of amphetamines in urine. , 2004, Forensic science international.
[21] Patrick S. Cardona,et al. Distribution and optical purity of methamphetamine found in toxic concentration in a civil aviation accident pilot fatality. , 2004, Journal of forensic sciences.
[22] R. Kostiainen,et al. Effect of the eluent on enantiomer separation of controlled drugs by liquid chromatography-ultraviolet absorbance detection-electrospray ionisation tandem mass spectrometry using vancomycin and native beta-cyclodextrin chiral stationary phases. , 2004, Journal of chromatography. A.
[23] N. Samyn,et al. Concentrations and ratios of amphetamine, methamphetamine, MDA, MDMA, and MDEA enantiomers determined in plasma samples from clinical toxicology and driving under the influence of drugs cases by GC-NICI-MS. , 2003, Journal of analytical toxicology.
[24] G. Rechberger,et al. Enantioselective trace analysis of amphetamine in human plasma by gas chromatography/negative ion chemical ionization mass spectrometry. , 2003, Rapid communications in mass spectrometry : RCM.
[25] P. Campíns-Falcó,et al. Strategies for the enantiomeric determination of amphetamine and related compounds by liquid chromatography. , 2002, Journal of biochemical and biophysical methods.
[26] A. Pirogov,et al. Separation and enantioseparation of derivatized amino acids and biogenic amines by high-performance liquid chromatography with reversed and chiral stationary phases. , 2002, Journal of chromatography. A.
[27] A. Lua,et al. Preparation of immunoaffinity columns for direct enantiomeric separation of amphetamine and/or methamphetamine. , 2002, Journal of chromatography. A.
[28] John T Cody,et al. Precursor Medications as a Source of Methamphetamine and/or Amphetamine Positive Drug Testing Results , 2002, Journal of occupational and environmental medicine.
[29] H. Maurer,et al. Toxicokinetics of Amphetamines: Metabolism and Toxicokinetic Data of Designer Drugs, Amphetamine, Methamphetamine, and Their N-Alkyl Derivatives , 2002, Therapeutic drug monitoring.
[30] Y. Ling,et al. Simultaneous supercritical fluid extraction and chemical derivatization for the gas chromatographic-isotope dilution mass spectrometric determination of amphetamine and methamphetamine in urine. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[31] F. Tagliaro,et al. Use of beta-cyclodextrin in the capillary zone electrophoretic separation of the components of clandestine heroin preparations. , 2001, Journal of chromatography. A.
[32] R. Braithwaite,et al. Using amphetamine isomer ratios to determine the compliance of amphetamine abusers prescribed dexedrine. , 2000, Journal of analytical toxicology.
[33] A. Kurosu,et al. Interpretation and enantiomer analysis of methamphetamine abusers' urine and illegally brewed methamphetamine crystals. , 2000, Journal of analytical toxicology.
[34] F. Musshoff,et al. ILLEGAL OR LEGITIMATE USE? PRECURSOR COMPOUNDS TO AMPHETAMINE AND METHAMPHETAMINE , 2000, Drug metabolism reviews.
[35] K. Matsubara,et al. Stereoselective analyses of selegiline metabolites: possible urinary markers for selegiline therapy. , 1999, Forensic science international.
[36] Ken Muranaka,et al. Precision and Accuracy (2) , 1998 .
[37] S. Valtier,et al. Detection of amphetamine and methamphetamine following administration of benzphetamine. , 1998, Journal of analytical toxicology.
[38] B. Cannon,et al. Carteolol is a weak partial agonist on beta 3-adrenergic receptors in brown adipocytes. , 1998, Canadian journal of physiology and pharmacology.
[39] G. Tucker,et al. Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6. , 1997, Drug metabolism and disposition: the biological fate of chemicals.
[40] J. Cody. Enantiomeric composition of amphetamine and methamphetamine derived from the precursor compound famprofazone. , 1996, Forensic science international.
[41] K. Lemr,et al. Capillary electrophoretic enantioseparation of selegiline, methamphetamine and ephedrine using a neutral beta-cyclodextrin epichlorhydrin polymer. , 1996, Journal of pharmaceutical and biomedical analysis.
[42] D. Armstrong,et al. Macrocyclic Antibiotics as a New Class of Chiral Selectors for Liquid Chromatography , 1994 .
[43] J. Cody,et al. Interpretation of methamphetamine and amphetamine enantiomer data. , 1993, Journal of analytical toxicology.
[44] B. Sadler,et al. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. , 1993, Drug metabolism and disposition: the biological fate of chemicals.
[45] R. Fitzgerald,et al. Resolution of methamphetamine stereoisomers in urine drug testing: urinary excretion of R(-)-methamphetamine following use of nasal inhalers. , 1988, Journal of analytical toxicology.
[46] A. Beckett,et al. Urinary Excretion of Methylamphetamine in Man , 1965, Nature.
[47] S. Gan,et al. Stereoselective method development and validation for determination of concentrations of amphetamine-type stimulants and metabolites in human urine using a simultaneous extraction-chiral derivatization approach. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[48] F. Tagliaro,et al. Recent advances in the applications of CE to forensic sciences (2005–2007) , 2008, Electrophoresis.
[49] A. M. Salazar,et al. Determination of amphetamine, methamphetamine, and hydroxyamphetamine derivatives in urine by gas chromatography-mass spectrometry and its relation to CYP2D6 phenotype of drug users. , 2007, Journal of analytical toxicology.
[50] K. Ameno,et al. Simultaneous determination of methamphetamine and its metabolite, amphetamine, in urine using a high performance liquid chromatography column-switching method. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[51] B. Cannon,et al. Arotinolol is a weak partial agonist on beta 3-adrenergic receptors in brown adipocytes. , 2001, Canadian Journal of Physiology and Pharmacology.